Nashrieh Shimi va Mohandesi Shimi Iran

Nashrieh Shimi va Mohandesi Shimi Iran

Development of a Cost Effective Purification Method for Human Epidermal Growth Factor (hEGF) in Recombinant Escherichia coli

Document Type : Research Note

Authors
Seyed Abbas Shojaosadati 1
Rasoul Khalilzadeh 2
Jafar Mohammadian 2
Vajiheh Khani 3
1 Faculty of Chemical Engineering, Tarbiat Modares University, Jalal Ale Ahmad Highway, P.O. Box 14115-114, Tehran, I.R. IRAN
2 Department of Bioscience and Biotechnology, Malek Ashtar University, Tehran, I.R. IRAN
3 Academic Center for Education, Culture and Research (ACECR), Yazd Branch, P.O.BOX 89415145 Yazd, I.R. IRAN
Abstract
Human Epidermal Growth Factor (hEGF) with 53 amino acids and a molecular weight of 6.2 KD is a protein that stimulates the growth of various cell types. The purpose of this study was to apply a novel method for purification of the recombinant hEGF that was expressed in recombinant Escherichia coli BL21(DE3). The recombinant strain produced hEGF in form of intracellular so it was necessary to disrupt cell wall of recombinant E. coli and then purify hEGF from inclusion body. Renaturation and purification protocol, which was used in this study, was a simple and efficient one that had three stages including unfolding, purification by means of ultrafiltration and centrifugation and finally refolding of unfolded rhEGF molecules. SDS-PAGE and Reverse Phase High Performance Liquid Chromatography (RP-HPLC) were used as analytical methods to investigate the results. The purified protein was analyzed by SDS-PAGE and RP-HPLC and the results were shown more than 99% purity.
Keywords
Recombinant human epidermal growth factor (rhEGF)
Purification
Recombinant Escherichia coli
Ultrafiltration

Subjects

[1] Sharma K., Cherish Babu P.V., Sasidhar  P., Srinivas V.K., Krishna Mohan V., Krishna Ella, Recombinant Human Epidermal Growth Factor Inclusion Body Solubilization and Refolding at Large Scale using Expanded-Bed Adsorption Chromatography from Escherichia coli, Protein Expression and Purification, 60: 7-14 (2008).
[2]  Huang R.C., Lam E., Chen Y.H., Hackett J, Lam T.L., Liu D., Ma M.C., Siu K.L., Sivakesava S., Xu Z.N., Wong R.S.C. Wong W.K.R., Human Epidermal Growth Factor Excreted by Recombinant Escherichia coli K-12 has the Correct N-Terminus and is Fully Bioactive, Process Biochem., 35: 1-5 (1999).
[3] شجاع‌الساداتی، سید عباس؛ خلیل‌زاده، رسول؛ محمدیان، جعفر؛ "کلونینگ و بیان فاکتور رشد اپیدرمی انسانی در باکتری اشرشیاکلی"، گزارش پروژه تحقیقاتی، صفحات2-20 (1386).
[4] Heo J.H., Won H.S., Kang H.A., Rhee S.K. Chung B.H., Purification of Recombinant Human Epidermal Growth Factor Secreted from the Methylotrophic Yeast Hansenula Polymeorpha, Protein Expression and Purification, 24: 117-122 (2002).
[5] Soler L.F., Cedano J., Querol E. Liorens R., Cloning, Expression and Purification of Human Epidermal Growth Factor using Different Expression Systems, Journal of Chromatography, 788: 113-123 (2003).
[6] Finkenaur, “Stabilized Compositions Containing Epidermal Growth Factor”, US Patent References, Publication Number EP 0267015 A2 (1988).
[7] Mount C.D., Lukas T.J., Orth D.N., Purification and Characterization of Epidermal Growth Factor and Epidermal Growth Factor Fragments from Large volumes of Human Urine, Arch Biochem. Biophys., 240: 33-42 (1985).
[8] Lee J.Y., Chang S.Y., Chung Y., Lee Y.S. Lee E.K., Scale-up Process for Expression and Renaturation of Recombinant Human Epidermal Growth Factor from Escherichia coli Inclusion Bodies, Biotechnol. Appl. Biochem., 31: 245-248 (2000).
[9] Lee Y.S., Suh C.W., Park S.K. Lee E.K., Purification of Soluble Human Epidermal Growth Factor (hEGF) from Recombinant Escherichia coli Culture Broth by Using Expanded-Bed Adsorption Chromatography, Biotechnol. Appl. Biochem., 38: 9-13 (2003).
[10] Abdull Razis A.F., Ismail E.N., Hambali Z., Abdullah M.N.H., Ali A.M. Mohd Lila M.A.,The Periplasmic Expression of Recombinant Human Epidermal Growth Factor (hEGF) in Escherichia coli, Asia Pacific Journal of Molecular Biology and Biotechnology, 14: 41-45 (2006).
[11] اسفندیار، سمانه؛ "خالص سازی اینترلوکین-2 تولید شده در باکتری اشرشیاکلی نوترکیب"، پایان‌نامه کارشناسی ارشد، دانشگاه تربیت ­مدرس (1387).
[12] Getz E.B., Xiao M., Chakrabarty T., Cooke R. Selvin P.R., A Comparison between the Sulfhydryl Reductants Tris(2-carboxyethyl)phosphine and Dithiothreitolfor Use in Protein Biochemistry, Analytical Biochem., 273: 73-80 (1999).
[13] Reddya G.B., Narayananb S., Reddya P.Y., Suroliab I., Suppression of DTT-Induced Aggregation of Abrin by KA- and KB-Crystallins: a Model Aggregation Assay for K-Crystallin Chaperone Activity in Vitro, Federation of European Biochemical Societies, 522: 59-64 (2002).
[14] Stevan Jovanovich, Carol J. Tillis, David L. Barker, “Handbook of Protein Purification”, Amersham Pharmacia Biotech, Uppsala Sweden (2001).